Hemab Therapeutics
PrivateLast Round
Series C
Oct 27, 2025
Total Funding Raised
$157M
Company Overview
Hemab Therapeutics operates in Healthcare & Life Sciences. Its latest recorded funding round was a Series C round in October 2025.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemab Therapeutics Comparables
Compare Hemab Therapeutics with similar companies based on industry and business-model similarity.
No comparables are published for Hemab Therapeutics. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Hemab Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Hemab Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maj Invest Equity A/S | Series C |
| RA Capital Management | Series C |
| Avoro Ventures | Series C |
| Avoro Capital | Series C |
| Deep Track Capital | Series C |
| HealthCap | Series C |
| Novo Holdings | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2025
$157M round raised.
For institutional investors. Book with your work email.
Hemab Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hemab Therapeutics's valuation, stock price, and market status.
Is Hemab Therapeutics a public or private company?
Hemab Therapeutics is a private company.
What is the current stock price of Hemab Therapeutics?
Hemab Therapeutics is a private company, so its shares have no public market price. Caplight tracks Hemab Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hemab Therapeutics worth (valuation)?
Valuation information for Hemab Therapeutics is not publicly available.
Can I buy Hemab Therapeutics stock?
Hemab Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hemab Therapeutics's last funding round?
Hemab Therapeutics's most recent funding round was Series C on October 27, 2025.
Who are the main investors in Hemab Therapeutics?
Key investors in Hemab Therapeutics include Sofinnova Partners.
Will Hemab Therapeutics IPO soon?
No public IPO plans have been announced for Hemab Therapeutics.
How can I track Hemab Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Hemab Therapeutics's shares on secondary markets.